References
GUaRDIAN Consortium. et al. Hum. Genomics 14, 52 (2019).
Anonymous Nat. Med. 27, 1311 (2021).
Fox, T. et al. Nat. Med. 29, 518–519 (2023).
Chokshi, M. et al. J. Perinatol. 36, S9–S12 (2016).
Mandal, S. et al. Lancet Glob. Health 9, e1197–e1200 (2021).
Acharya, S. et al. Proc. Natl Acad. Sci. USA 116, 20959–20968 (2019).
Ghosh, A. et al. Mol. Ther. 16, 124–130 (2008).
Ministry of Health & Family Welfare. National Guidelines for Gene Therapy Product Development and Clinical Trials; https://main.icmr.nic.in/sites/default/files/guidelines/guidelines_GTP.pdf (2019).
Graff, G. D. & Sherkow, J. S. Annu. Rev. Genomics Hum. Genet. 21, 509–534 (2020).
Ikawa, Y. et al. Hum. Mol. Genet. 28, R24–R30 (2019).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Ghosh, A., Maiti, S. & Chakraborty, D. Emerging opportunities for gene editing therapies in India. Nat Med 30, 324–325 (2024). https://doi.org/10.1038/s41591-023-02752-3
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-023-02752-3
- Springer Nature America, Inc.